CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024. CRISM Therapeutics Corporation was founded in 2016 and is based in Road Town, the British Virgin Islands.
Metrics to compare | CRTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCRTXPeersSector | |
---|---|---|---|---|
P/E Ratio | −7.1x | −3.4x | 2.2x | |
PEG Ratio | −0.07 | 0.01 | 0.00 | |
Price/Book | 2.8x | 0.9x | 1.6x | |
Price / LTM Sales | 167.8x | 15.4x | 1.3x | |
Upside (Analyst Target) | - | 239.0% | 20.0% | |
Fair Value Upside | Unlock | 11.1% | 2.4% | Unlock |